Harrington WJ, Sprague CC, Minnich V, et al. Immunologic mechanisms in neonatal and thrombocytopenic purpura. Ann Intern Med 1953;38:433–69.10.7326/0003-4819-38-3-433Search in Google Scholar
Moulinier J. Alloimmunisation maternelle antiplaquettaire “Duzo.” Proc 6th Congr Eur Soc Haematol 1953;817–20.Search in Google Scholar
Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol 1996;13:423–31.10.1055/s-2007-994382Search in Google Scholar
Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92:2280–7.10.1182/blood.V92.7.2280Search in Google Scholar
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–6.10.1182/blood.V70.6.1722.1722Search in Google Scholar
McMillan R. Antigen-specific assays in immune thrombocytopenia. Transfus Med Rev 1990;4: 136–43.10.1016/S0887-7963(90)70258-1Search in Google Scholar
von dem Borne AEGKr, Decary F. Nomenclature of platelet specific antigens. Br J Haematol 1990;74: 239–40.Search in Google Scholar
Metcalfe P, Watkins NA, Ouwehand WH, et al. Nomenclature of human platelet antigens. Vox Sang 2003;85:240–5.10.1046/j.1423-0410.2003.00331.xSearch in Google Scholar
Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363–6.10.1016/S0140-6736(89)91733-9Search in Google Scholar
Kaplan C, Morel-Kopp MC, Kroll H, et al. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991;78:425–9.10.1111/j.1365-2141.1991.tb04459.x1873226Search in Google Scholar
Glade-Bender J, McFarland JG, Kaplan C, Porcelijn L, Bussel JB. Anti-HPA-3a induces severe neonatal alloimmune thrombocytopenia. J Pediatr 2001; 138:862–7.10.1067/mpd.2001.11402911391330Search in Google Scholar
Kroll H, Yates J, Santoso S. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens. Transfusion 2005;45:353–8.10.1111/j.1537-2995.2005.04218.x15752152Search in Google Scholar
Kaplan C, Porcelijn L, Vanlieferinghen Ph, et al. Anti-HPA-9bw (Maxa) feto-maternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy, report on 8 families. Transfusion 2005;45: 1799–803.10.1111/j.1537-2995.2005.00606.xSearch in Google Scholar
Peterson JA, Balthazor SM, Curtis BR, McFarland JG, Aster RH. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max) is an important cause of neonatal alloimmune thrombocytopenia. Transfusion 2005;45:1487–95.10.1111/j.1537-2995.2005.00561.xSearch in Google Scholar
Morel-Kopp MC, Daviet L, McGregor J, Kaplan C. Drawbacks of the MAIPA technique in characterising human antiplatelet antibodies. Blood Coagul Fibrinolysis 1996;7:144–6.10.1097/00001721-199603000-00007Search in Google Scholar
Kroll H, Penke G, Santoso S. Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1a. Thromb Haemost 2005; 94:1224–9.10.1160/TH05-03-0159Search in Google Scholar
Valentin N, Vergracht A, Bignon JD, et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990;27:73–9.10.1016/0198-8859(90)90104-WSearch in Google Scholar
L’Abbe D, Tremblay L, Filion M, et al. Alloimmunization to platelet antigen HPA-1a (PlA1) is strongly associated with both HLA-DR3*0101 and HLA-DQB1*0201. Hum Immunol 1992;34: 107–14.10.1016/0198-8859(92)90036-MSearch in Google Scholar
Kuijpers RWAM, von dem Borne AEGKr, Kiefel V, et al. Leucine33-proline33 substitution in human platelet glycoprotein IIIa determines HLA-DRw52a (Dw24) association of the immune response against HPA-1a (Zwa/PlA1) and HPA-1b (Zwb/PlA2). Hum Immunol 1992;34:253–6.10.1016/0198-8859(92)90024-HSearch in Google Scholar
Maslanka K, Yassai M, Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 1996;98:1802–8.10.1172/JCI118980Search in Google Scholar
Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997;158: 3221–6.Search in Google Scholar
Semana G, Zazoun T, Alizadeh M, et al. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization. Role of HLA class II and TAP genes. Hum Immunol 1996;46:114–9.10.1016/0198-8859(96)00019-5Search in Google Scholar
Westman P, Hashemi-Tavoularis S, Blanchette V, et al. Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GP IIIa-Gln489). Tissue Antigens 1997;50:113–8.10.1111/j.1399-0039.1997.tb02849.x9271820Search in Google Scholar
Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45–55.10.1111/j.1479-828X.2001.tb01293.xSearch in Google Scholar
Kiefel V, Bassler D, Kroll H, et al. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood 2006;107: 3761–3.10.1182/blood-2005-06-2235Search in Google Scholar
Allen D, Verjee S, Rees S, Murphy MF, Roberts DJ. Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood 2007;109:388–9.10.1182/blood-2006-05-026419Search in Google Scholar
Daffos F, Capella-Pavlosky M, Forestier F. A new procedure for fetal blood sampling in utero: preliminary results. Am J Obstet Gynecol 1983; 146:985–7.10.1016/0002-9378(83)90982-1Search in Google Scholar
Forestier F, Daffos F, Galacteros F, et al. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res 1986;20:342–6.10.1203/00006450-198604000-00017Search in Google Scholar
Daffos F, Forestier F, Muller JY, et al. Prenatal treatment of alloimmune thrombocytopenia. Lancet 1984;2:632.10.1016/S0140-6736(84)90614-7Search in Google Scholar
Kaplan C, Daffos F, Forestier F, et al. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988;72:340–3.10.1182/blood.V72.1.340.340Search in Google Scholar
Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood 1994;84: 1851–6.10.1182/blood.V84.6.1851.1851Search in Google Scholar
Murphy MF, Pullon HW, Metcalfe P, et al. Management of fetal alloimmune thrombocytopenia by weekly in utero platelet transfusions. Vox Sang 1990;58:45–9.10.1111/j.1423-0410.1990.tb02054.x2316210Search in Google Scholar
Overton TG, Duncan KR, Jolly M, Letsky E, Fisk NM. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: platelet dynamics and perinatal outcome. Am J Obstet Gynecol 2002;186:826–31.10.1067/mob.2002.12214011967515Search in Google Scholar
Bussel JB, Berkowitz RL, Lynch L, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 1996;174:1414–23.10.1016/S0002-9378(96)70582-3Search in Google Scholar
Kaplan C, Murphy MF, Kroll H, Waters AH. Fetomaternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids—more questions than answers. Br J Haematol 1998; 100:62–5.10.1046/j.1365-2141.1998.00533.xSearch in Google Scholar
Birchall JE, Murphy MF, Kaplan C, Kroll H, on behalf of the European Fetomaternal Alloimmune Thrombocytopenia Study Group. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003;122:275–88.10.1046/j.1365-2141.2003.04408.xSearch in Google Scholar
Engelfriet CP, Reesink HW, Kroll H, et al. Prenatal management of alloimmune thrombocytopenia of the fetus. Vox Sang 2003;84:142–9.10.1046/j.1423-0410.2003.00269.xSearch in Google Scholar
Paidas MJ, Berkowitz RL, Lynch L, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995;172:475–9.10.1016/0002-9378(95)90559-6Search in Google Scholar
Radder CM, Brand A, Kanhai HH. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 2001; 185:683–8.10.1067/mob.2001.11672711568798Search in Google Scholar
Kanhai HHH, van den Akker ESA, Walther FJ, Brand A. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage. Fetal Diagn Ther 2006;21:55–60.10.1159/00008904816354976Search in Google Scholar
Berkowitz RL, Kolb EA, McFarland JG, et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 2006;107:91–6.10.1097/01.AOG.0000192404.25780.6816394045Search in Google Scholar
Turner ML, Bessos H, Fagge T, et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005;45:1945–56.10.1111/j.1537-2995.2005.00645.x16371049Search in Google Scholar
Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997;89:4402–6.10.1182/blood.V89.12.4402Search in Google Scholar
Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006;4:628–37.10.1111/j.1538-7836.2006.01809.x16460445Search in Google Scholar
Ni H, Chen P, Spring CM, et al. A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood 2006;107:2976–83.10.1182/blood-2005-06-2562189538716317099Search in Google Scholar
